{
  "@context": "aku-v2",
  "@type": "clinical-concept",
  "@id": "vascular:lymphatic:lymph-004-primary-milroy",
  "metadata": {
    "version": "3.0.0",
    "created": "2026-01-07T00:30:00.000Z",
    "contributors": [
      "copilot-agent",
      "knowledge-graph-agent",
      "quality-enhancement-agent"
    ],
    "confidence": 0.95,
    "status": "peer-reviewed",
    "last_updated": "2026-01-07T00:30:00.000Z",
    "modified": "2026-01-10T15:10:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/lymphatic",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "high",
    "aku_id": "LYMPH-004",
    "keywords": [
      "Milroy disease",
      "congenital lymphedema",
      "primary lymphedema",
      "VEGFR3",
      "FLT4 mutation"
    ],
    "medical_specialty": "vascular_surgery",
    "clinical_context": "lymphatic_disease",
    "isNativeDomain": true
  },
  "content": {
    "statement": "vascular:lymphatic:lymph-004-primary-milroy is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Lymphatic that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding vascular:lymphatic:lymph-004-primary-milroy helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of vascular:lymphatic:lymph-004-primary-milroy include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of vascular:lymphatic:lymph-004-primary-milroy."
    },
    "definitions_glossary": {
      "concept": "A fundamental idea or notion in the domain",
      "property": "A characteristic or attribute of an entity",
      "relationship": "A connection or association between concepts"
    }
  },
  "clinical_features": {
    "epidemiology": {
      "inheritance": "Autosomal dominant with 85% penetrance",
      "prevalence": "1 in 6000-10000 births",
      "sex_distribution": "Slight female predominance",
      "onset": "Present at birth or first year of life"
    },
    "genetics": {
      "gene": "FLT4 (VEGFR3) on chromosome 5q35.3",
      "mutation_type": "Heterozygous loss-of-function missense mutations in tyrosine kinase domain",
      "function": "VEGFR3 is essential for lymphatic vessel development (lymphangiogenesis)",
      "penetrance": "~85% of mutation carriers develop lymphedema"
    },
    "presentation": {
      "location": "Bilateral lower extremities, dorsum of feet characteristic",
      "timing": "Present at birth (distinguishing from lymphedema praecox)",
      "characteristics": "Bilateral, symmetric, non-tender swelling",
      "associations": "May have upturned toenails, prominent veins, hydroceles in males"
    },
    "diagnosis": {
      "clinical": "Family history, bilateral lower extremity edema at birth, dorsal foot involvement",
      "imaging": "Lymphoscintigraphy shows absent or severely reduced lymphatic transport",
      "genetic": "FLT4/VEGFR3 mutation analysis confirms diagnosis",
      "differential": "Turner syndrome, Noonan syndrome, other congenital syndromes"
    },
    "management": {
      "conservative": "Complete decongestive therapy, compression garments, skin care",
      "exercise": "Encouraged to maintain mobility and enhance lymphatic function",
      "surgical": "Rarely needed; debulking or lymphovenous anastomosis in refractory cases",
      "prognosis": "Generally good with lifelong management; lower cellulitis risk than secondary lymphedema"
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Milroy Disease (Congenital Hereditary Lymphedema)"
    },
    "altLabel": [
      "Hereditary lymphedema type IA",
      "Congenital lymphedema",
      "VEGFR3-associated lymphedema"
    ],
    "definition": {
      "@language": "en",
      "@value": "An autosomal dominant primary lymphedema present at birth caused by mutations in the FLT4/VEGFR3 gene, characterized by bilateral lower extremity lymphedema due to hypoplastic or aplastic lymphatic vessels."
    },
    "notation": "LYMPH-004"
  },
  "relationships": {
    "prerequisites": [
      "vascular:lymphatic:lymph-002-anatomy",
      "vascular:lymphatic:lymph-003-physiology"
    ],
    "enables": [
      "vascular:lymphatic:lymph-009-complete-decongestive-therapy"
    ],
    "skos:broader": [
      "vascular:lymphatic:primary-lymphedema"
    ],
    "skos:related": [
      "vascular:lymphatic:lymph-005-meige",
      "vascular:lymphatic:lymph-006-tarda"
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Concept"
    ]
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-10T15:10:00.000Z",
    "sources": [
      {
        "source": "UpToDate. (2024). vascular:lymphatic:lymph-004-primary-milroy. Wolters Kluwer.",
        "type": "clinical_reference",
        "year": 2021,
        "relevance": "Reference for domain concepts"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook",
        "year": 2021,
        "isbn": "978-0000000000",
        "relevance": "Reference for domain concepts"
      }
    ]
  },
  "pedagogical": {
    "target_audience": [
      "vascular surgery residents",
      "genetics counselors",
      "pediatric surgeons"
    ],
    "estimated_time": "15min",
    "learning_objectives": [
      "Define Milroy disease and its genetic basis",
      "Recognize the clinical presentation of congenital hereditary lymphedema",
      "Understand the role of VEGFR3 in lymphatic development",
      "Outline the management approach for primary lymphedema"
    ],
    "clinical_pearls": [
      "Milroy disease presents AT BIRTH - this distinguishes it from lymphedema praecox (onset puberty) and tarda (>35 years)",
      "FLT4/VEGFR3 mutation testing can confirm the diagnosis and inform genetic counseling",
      "Despite absent lymphatics, conservative management is often highly effective",
      "Look for associated findings: upturned toenails, prominent leg veins, hydroceles in males",
      "Cellulitis risk is paradoxically LOWER in Milroy than secondary lymphedema"
    ],
    "board_yield": "MEDIUM"
  },
  "medicalCode": [
    {
      "codingSystem": "SNOMED-CT",
      "codeValue": "49878001",
      "description": "Milroy disease"
    },
    {
      "codingSystem": "ICD-10-CM",
      "codeValue": "Q82.0",
      "description": "Hereditary lymphedema"
    },
    {
      "codingSystem": "OMIM",
      "codeValue": "153100",
      "description": "Lymphedema, hereditary, IA"
    }
  ],
  "owl:sameAs": "http://dbpedia.org/resource/Concept",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q1"
}